erlotinib hydrochloride has been researched along with Neoplasms, Skull in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asklund, T; Henriksson, R; Riklund, K; Sandström, M; Shahidi, S | 1 |
1 other study(ies) available for erlotinib hydrochloride and Neoplasms, Skull
| Article | Year |
|---|---|
Durable stabilization of three chordoma cases by bevacizumab and erlotinib.
Topics: Adult; Antibodies, Monoclonal, Humanized; Bevacizumab; Bone Neoplasms; Chordoma; Erlotinib Hydrochloride; Female; Humans; Male; Middle Aged; Quinazolines; Sacrum; Skull Neoplasms; Treatment Outcome | 2014 |